Prevention of Cardiovascular Events
📧 Sign up to get email alerts when something new happens for Prevention of Cardiovascular Events.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2026-08-17FDA Approved: ROSUVASTATIN CALCIUM — Supplemental Application (Glenmark Pharmaceutials Inc., USA)
FDA supplemental approval for a rosuvastatin calcium product from Glenmark Pharmaceuticals Inc. USA.
-
FDA approval · 2023-07-10FDA Approved: ATORVASTATIN CALCIUM — Supplemental Application (Rising Pharma Holdings, Inc.)
The FDA approved a supplemental application for atorvastatin calcium film-coated tablets from Rising Pharma Holdings, Inc., supporting a gen…
-
FDA approval · 2011-09-27FDA Approved: PRAVASTATIN SODIUM — Supplemental Application (Aurobindo Pharma Limited)
FDA approved a supplemental application for Pravastatin Sodium by Aurobindo Pharma Limited.